Abstract: The membrane protein Nogo-A is known as an inhibitor of axonal outgrowth and regeneration in the CNS. However, its physiological functions in the normal adult CNS remain incompletely understood. Here, we investigated the role of Nogo-A in cortical synaptic plasticity and motor learning in the uninjured adult rodent motor cortex. Nogo-A and its receptor NgR1 are present at cortical synapses. Acute treatment of slices with function-blocking antibodies (Abs) against Nogo-A or against NgR1 increased long-term potentiation (LTP) induced by stimulation of layer 2/3 horizontal fibers. Furthermore, anti-Nogo-A Ab treatment increased LTP saturation levels, whereas long-term depression remained unchanged, thus leading to an enlarged synaptic modification range. In vivo, intrathecal application of Nogo-A-blocking Abs resulted in a higher dendritic spine density at cortical pyramidal neurons due to an increase in spine formation as revealed by in vivo two-photon microscopy. To investigate whether these changes in synaptic plasticity correlate with motor learning, we trained rats to learn a skilled forelimbreaching task while receiving anti-Nogo-A Abs. Learning of this cortically controlled precision movement was improved upon anti-Nogo-A Ab treatment. Our results identify Nogo-A as an influential molecular modulator of synaptic plasticity and as a regulator for learning of skilled movements in the motor cortex. The membrane protein Nogo-A is known as an inhibitor of axonal outgrowth and regeneration in the CNS. However, its physiological functions in the normal adult CNS remain incompletely understood. Here, we investigated the role of Nogo-A in cortical synaptic plasticity and motor learning in the uninjured adult rodent motor cortex. Nogo-A and its receptor NgR1 are present at cortical synapses. Acute treatment of slices with function-blocking antibodies (Abs) against Nogo-A or against NgR1 increased long-term potentiation (LTP) induced by stimulation of layer 2/3 horizontal fibers. Furthermore, anti-Nogo-A Ab treatment increased LTP saturation levels, whereas long-term depression remained unchanged, thus leading to an enlarged synaptic modification range. In vivo, intrathecal application of Nogo-A-blocking Abs resulted in a higher dendritic spine density at cortical pyramidal neurons due to an increase in spine formation as revealed by in vivo two-photon microscopy. To investigate whether these changes in synaptic plasticity correlate with motor learning, we trained rats to learn a skilled forelimb-reaching task while receiving anti-Nogo-A Abs. Learning of this cortically controlled precision movement was improved upon anti-Nogo-A Ab treatment. Our results identify Nogo-A as an influential molecular modulator of synaptic plasticity and as a regulator for learning of skilled movements in the motor cortex.
Introduction
Activity-driven long lasting changes in the efficacy of synaptic transmission can be expressed as long-term potentiation (LTP) or long-term depression (LTD) and can correlate with structural modifications, for example, at dendritic spines . Both, functional and structural synaptic plasticity have been shown to serve as underlying mechanisms for learning and memory in several regions of the brain (Marr, 1969; Morris et al., 1986; Ito, 2001; Kandel, 2001; Whitlock et al., 2006; Holtmaat and Svoboda, 2009; , including acquisition of novel motor skills (Rioult-Pedotti et al., 1998; Rioult-Pedotti et al., 2000; Harms et al., 2008; Xu et al., 2009; Fu et al., 2012 ; but also see Cohen and Castro-Alamancos 2005; Welsh et al., 2005; Llinás, 2011) .
The membrane protein Nogo-A was originally identified as a myelin-associated neurite outgrowth inhibitor in the adult CNS (Caroni and Schwab, 1988; Chen et al., 2000) . Neutralization of Nogo-A, of its receptor NgR1, or inhibition of the downstream signaling cascades via Rho-A and Rho-associated protein kinase (ROCK) enhance regenerative and compensatory fiber growth and improve functional recovery after CNS injury or stroke (Schnell and Schwab, 1990; Chen et al., 2000; GrandPré et al., 2002; Fournier et al., 2003; Kim et al., 2004; Liebscher et al., 2005; Gonzenbach and Schwab, 2008; Akbik et al., 2012) . In addition to its source in oligodendrocytes, Nogo-A is expressed by subtypes of neurons, especially in plastic areas such as the hippocampus, neocortex, and the subventricular zone/olfactory bulb system (Huber et al., 2002; Wang et al., 2002; Grunwald et al., 2004; Raiker et al., 2010; Rolando et al., 2012) . In the hippocampus, neuronal Nogo-A and its receptor, NgR1, negatively modulate functional synaptic plasticity (Lee et al., 2008; Raiker et al., 2010; Delekate et al., 2011) .
Structurally, neutralization or ablation of Nogo-A or NgR1 increase axonal growth, modulate dendritic branching, and enhance spine turnover rate and density (Craveiro et al., 2008; Zagrebelsky et al., 2010; Wills et al., 2012; Akbik et al., 2013) . In the visual and the somatosensory cortex, genetic ablation of Nogo-A/B, of NgR1, or of the Nogo-binding partner Paired Ig-like Receptor B (PirB) prolong plasticity of ocular dominance columns far into adult age in mice (McGee et al., 2005; Syken et al., 2006; Akbik et al., 2013) . Together, these studies reveal a role for Nogo signaling in remodeling of synaptic strength and structure (Akbik et al., 2012; Mironova and Giger, 2013) . Whether Nogo-A impacts cortically controlled learning is currently unknown.
Here, we investigated the influence of Nogo-A signaling on functional and structural synaptic plasticity in the motor cortex of adult rats and mice and during motor learning in vivo. At an ultrastructural level, we confirmed the presence of Nogo-A and NgR1 at synaptic sites of the motor cortex. Functional neutralization of Nogo-A or of NgR1 by Abs increased electrically induced synaptic strength (LTP) within minutes and spine density of pyramidal neurons in vivo within days. Motor learning of a skilled forelimb-reaching task in rats was improved upon antiNogo-A Ab treatment. Our results identify Nogo-A as an influential molecular modulator of synaptic plasticity and learning in the motor cortex.
Materials and Methods
Animals. Adult male Sprague Dawley rats (5-6 weeks, 190 -220 g; Janvier) were used for LTP, LTD, in vivo motor learning, and electron microscopy experiments. Rats were housed in standard cages in groups of three animals per cage in a reversed light/dark cycle (light on 8:00 P.M., light off 8:00 A.M.). All experiments were conducted with the approval of the Veterinarian Office Zurich, Switzerland, and in accordance with their guidelines. Thy1-YFP-H line mice (Feng et al., 2000) were purchased from Jackson Laboratory for in vivo imaging of dendritic spines (Table  2) . Mice were housed and bred in University of California-Santa Cruz animal facilities according to approved animal protocols.
Localization of Nogo-A and NgR1 in the motor cortex. Animals were deeply anesthetized with Nembutal and fixed by perfusion through the heart with 4% buffered PFA. Brains were dissected, postfixed overnight at 4°C, cryoprotected in 30% sucrose, and sectioned at 40 m in a cryostat. The sections were stored in antifreeze solution containing glucose and ethylene glycol (Willi et al., 2010) . For all staining, free-floating coronal sections were used. For Nogo-A identification in the motor cortex, immunoperoxidase staining was used with a rabbit primary antiNogo-A antiserum ("Laura," diluted 1:250; Oertle et al., 2003) diluted in 4% normal goat serum in phosphate buffer (PB) 0.1 M, pH 7.4, with 0.05% Triton X-100. The sections were then rinsed with buffer, incubated with a biotinylated secondary anti-rabbit Ab (1:300; Jackson ImmunoResearch), and processed for avidin-peroxidase staining (Vectastain Elite Kits; Vector Laboratories) with diaminobenzidine hydrochloride (Sigma-Aldrich) as the chromogen. For NgR1 detection and double staining for synaptophysin, immunofluorescence with following primary Abs was used: mouse monoclonal anti-Nogo-A Ab 11C7 (1 g/ml; Oertle et al., 2003) , goat anti-NgR (1:100; R&D Systems), rabbit anti-synaptophysin (1:500; Synaptic Systems), and fluorescent deep red Nissl stain NeuroTrace 640/660 (1:200; Invitrogen). The secondary Abs were raised in donkey coupled to indocarbocyanine Cy3 or to Alexa Fluor 488. After final washing steps in PB, sections were mounted and coverslipped with Mowiol (Calbiochem). Epifluorescence was analyzed in a sequential image acquisition mode by confocal microscopy (TCS SP2; Leica) using 20ϫ or 100ϫ objectives.
Immunoelectron microscopy. We used a pre-embedding immunolocalization technique because Nogo-A, like many antigens, can be detected only very weakly after dehydration, osmium fixation, and Epon-Araldite embedding. To detect Nogo-A and NgR1 in the motor cortex, we used the DAB-Ag-Au substitution method (Petrinovic et al., 2013) . The resulting DAB-Ag product was stabilized with gold chloride. The disadvantage of this method is the known unspecific staining of myelin by the gold chloride (Schmued, 1990; Schmued et al., 2008) . The sparse myelin structures in the cortical layer 2/3, which are known to be Nogo-Apositive (Huber et al., 2002) , were therefore excluded from the present analysis.
For pre-embedding immunolocalization of vGlut-1, Nogo-A, and NgR1, 40-m-thick coronal cryostat sections were prepared from M1 layer 2/3, treated with 0.5% NaBH 4 in Tris-buffered saline (TBS) for 10 min and in 50 mM Tris glycine, pH 8.0, for 30 min to quench the free aldehyde groups. After freeze and thaw cycles to enhance the permeability, sections were rinsed several times in TBS and incubated for 2 d with the primary Ab (vGlut1, 1:500; Nogo-A/Laura, 1:200; NgR1, 1:100) at 4°C on a shaker. Exposition to biotinylated secondary Ab (1:200; Jackson For a total 2 of 249 and 4 degrees of freedom (2-1 groups ϫ 5-1 compartments). Significant labeling is observed in the presynaptic terminal ( p Ͻ 0.0001; 2 test). The distribution of HRP DAB-gold product is not random and the bold values of RLI show the preferential labeling of compartments (RLI Ͼ 1). *** p Ͻ 0.001.
ImmunoResearch) was followed by Streptavidin Peroxidase ABC Elite Kit (1:100; Vector Laboratories). Sections were subsequently incubated with 0.025% 3,3Ј-diaminobenzidine tetrahydrochloride (DAB) in the presence of 0.006% H 2 O 2 for 5-10 min. DAB staining was intensified by the methenamine silver-gold reaction as described previously (Fritschy et al., 1999; Petrinovic et al., 2013) . Sections were osmicated and, after uranyl acetate contrast incubation, embedded in epoxy. Ultrathin sections of 100 nm were analyzed in a Zeiss EM10 electron microscope. For quantification of DAB-gold particles, electron microscopic images were randomly obtained from motor cortex layer 2/3 of three Sprague Dawley rats. The number of DAB-gold-positive compartments was divided by the total number of counted compartments (n ϭ 480) per antigen.
For synaptic distribution and quantity of Nogo-A, NgR1, and vGlut-1, 30 micrographs from the motor cortex 2/3 of three animals were randomly acquired at 63,000ϫ on a transmission electron microscope (Zeiss). The volume densities of DAB-gold-positive substructures in five compartments were determined stereologically by overlaying point grid matrix (ImageJ plugin) to count and calculate the relative labeling index and 2 square p-values of DAB-gold-positive compartments (Table 1) . Abs for ex vivo slice physiology experiments. Four different highly purified mouse and goat Abs were used: (1) a monoclonal, Nogo-A specific, function-blocking Ab raised against an 18 aa peptide in the most active region of Nogo-A (Ab 11C7 (Oertle et al., 2003; Liebscher et al., 2005; Maier et al., 2009 ; gift from Novartis Pharma); (2) a control mouse IgG Ab (AbD Serotec), (3) an Ab against the Nogo receptor subunit NgR1 (mNogo receptor affinity-purified goat IgG; lot #INQ02; R&D Systems), which was shown effective in hippocampal slice recordings (Delekate et al., 2011) ; and (4) a goat IgG control Ab (R&D Systems). Ab solutions were freshly prepared in carbogenated artificial CSF (ACSF) at a final concentration of 5 g/ml. To prevent sticking of the Ab to the tubing and the chamber, silicon tubing was used and washed with ACSF containing BSA (0.1 mg/ml). The slices were preincubated for at least 1 hour with the anti-Nogo-A, anti-NgR1, or the respective control Abs in an incubation chamber maintaining a constant flow of the solution. The Nogo-66 antagonist peptide Nep1-40 (N7161; Sigma-Aldrich) was dissolved in distilled water according to the manufacturer's instructions and used at a final concentration of 300 nM in ACSF. For in vivo experiments, the Nogo-A-specific blocking Ab and mouse IgG control Ab were used at a concentration of 3.0 -4.2 mg/ml in PBS.
Slice preparation. Coronal slices containing the forelimb area of M1 at 1-2 mm anterior to bregma (Donoghue and Wise, 1982) were prepared from adult Sprague Dawley rats (180 -220 g body weight) as described previously (Hess and Donoghue, 1996; Rioult-Pedotti et al., 1998) . Animals were anesthetized by intraperitoneal injection of pentobarbital. After decapitation, the brain was removed quickly and coronal slices, ϳ500 m thick, were cut using a vibratome (Leica Biosystems). Identical conditions were used to detect propidium iodide (PI)-positive cells. Slices were incubated with PI (2.5 g/ml) for 60 min, washed in ACSF, fixed in 4% PFA, and cryoprotected in 30% sucrose. Cross-sections of the slices were cut in a cryostat, mounted, and analyzed under a confocal microscope.
Electrophysiological recordings. Slices were stimulated using concentric bipolar microelectrodes (FHC) placed ϳ2-4 mm lateral to the midline and ϳ250 -400 pm below the pial surface. Field potentials (FPs) were recorded using glass micropipettes placed ϳ500 m lateral to the stimulating electrodes. To allow optimal Ab penetration, we recorded responses from the surface of layer 2/3 within M1. Protocols for inputoutput (IO) analysis, baseline stimulation intensity, and LTP induction were as described previously (Rioult-Pedotti et al., 1998; Rioult-Pedotti et al., 2000) . The theta-burst stimulation protocol for LTP induction was induced until responses were saturated. Pathways were considered saturated if the difference between two subsequent states of LTP was not significantly different (Rioult-Pedotti et al., 2000) . Saturated LTP was calculated as a percentage of baseline. LTD was attempted by lowfrequency stimulation (LFS; 2 Hz for 15 min at double baseline stimulation intensity). LFS was induced for four times (referred to as maximum LTD). Maximum LTD values were computed as percentages of baseline. In contrast to measuring the slope of the FP, as done in most hippocampal recordings, we used the FP amplitude because it serves as a measure of the population excitatory synaptic response (Rioult-Pedotti et al., 1998) , reflects a monosynaptic current sink (Hess et al., 1996) , and correlates well with the intracellular excitatory postsynaptic response evoked in this pathway (Aroniadou and Keller, 1995) .
Presynaptic properties were investigated through paired-pulse measurements, which were performed by applying a pair of two stimuli in different interstimulus intervals in a range of 10, 20, 40, 80, and 160 ms. The amplitude of the second response was divided by the amplitude of the first response. The result was expressed as the paired-pulse ratio.
Data analysis electrophysiology. Experimental data were collected with LabView software (National Instruments) and analyzed with LabView, MATLAB (MathWorks), Prism (GraphPad), and Excel (Microsoft) software. Horizontal fibers in layer 2/3 of the motor cortex were stimulated and the amplitude of elicited fEPSPs was measured over time, normalized to baseline values, and plotted as average Ϯ SEM.
Analysis of kinetics. The kinetics of the field response were characterized by rise time and decay time. The rise time was estimated from the 30/70 time (the time it takes the signal to transition from 30% to 70% of its maximal value or peak amplitude). Decay time constants were estimated by fitting the decaying phase of the field to a sum of two or three decaying exponentials (Levenberg-Marquardt nonlinear least squares). Decay time reported in the results section refers to the fastest decay time constant obtained by the fitting. The onset of the field response was further characterized by its onset latency and time to peak. The onset latency was obtained as the time interval between the stimulation and response onsets. The time to peak was determined as the time interval between stimulation onset and the field response maximum. All time constants were obtained individually for a total of 1148 trials corresponding to n ϭ 16 slices (eight treated with anti-Nogo and eight controls). For each slice, the median across trials was computed to reduce the effects of outliers. Each group was finally described by the mean of the individual medians.
Penetration of monoclonal anti-Nogo-A Abs into acute brain slices. Acute slices (500 m) of the forebrain of adult rats, incubated in mouse anti-Nogo-A Ab 11C7 (5 g/ml) for 1 h, as prepared for electrophysiology (see Electrophysiological recordings), were subsequently fixed in phosphate-buffered 4% PFA. After washing, the slices were transferred to 30% sucrose in PB, flat embedded in Tissue-Tek, and 40 m sections were cut in the perpendicular on a cryostat. These sections were then incubated with a Cy3-conjugated goat anti-mouse IgG Fc␥ subclass 1-specific Ab (1:200; Jackson ImmunoResearch). The distribution of the anti-Nogo-A mouse IgGs within the tissue was imaged with an Axioplan microscope (Zeiss) equipped with a MCID software module or a Leica Confocal Microscope TCS SP2.
Intrathecal catheter implantation and pump insertion. Animals were anesthetized with a subcutaneous injection of Hypnorm (600 l/kg body weight; VetPharm) and Dormicum (750 l/kg body weight; Roche Pharmaceuticals). After partial laminectomy at the T3 vertebral level, a fine intrathecal catheter (32 Ga; Recathco) was inserted into the subarachnoid space from the lumbar level L2/L3 and pushed rostrally to the spinal segment C7, delivering the Abs from an osmotic minipump (10 l/h, 2ML1; Alzet Osmotic Pumps) into the CSF. Abs were continuously delivered into the CSF for 7 d as described previously Willi et al., 2010) . Sham animals received all surgical steps except for catheter implantation and pump insertion.
In vivo transcranial imaging and data quantification. YFP-H line mice (Feng et al., 2000) of both sexes at 1 month of age were used in all experiments. The surgical procedure for transcranial two-photon imaging of the forelimb motor cortex and data quantification have been described previously (Xu et al., 2009) . Intrathecal catheters and pumps for Ab application were implanted as described in the paragraph "Intrathecal catheter implantation and pump insertion" immediately after the first imaging session. The second time images were obtained 6 d later. Percentages of eliminated and formed spines were normalized to total spines counted in the first images. Thinned-skull preparation was used in this study. Briefly, mice at 1 month of age were anesthetized with an intraperitoneal injection (5.0 ml/kg body weight) of 17 mg/ml ketamine and 1.7 mg/ml xylazine in 0.9% NaCl. The skull was exposed with a midline scalp incision and imaged regions were located based on stereotactic Anti-Nogo-A antibodies increase synaptic plasticity in the rat primary motor cortex. Rat coronal brain slices containing the forelimb region of the primary motor cortex were treated with a function blocking anti-Nogo-A antibody (Ab) (green) or a control Ab (orange). Insets show representative field potential (FP) waveforms obtained from layer 2/3 neurons taken at time points indicated by numbers in each figure. Up arrows: LTP induction, down arrows: LTD induction. A, During the last 20 minutes of saturated LTP, a significant difference between anti-Nogo-A treated (n ϭ 14) and control Ab treated slices (n ϭ 10) is observed ( p ϭ 0.038; t-test). LTP induction in anti-Nogo-A treated slices fails in presence of the NMDA receptor (NMDAR) antagonist AP-5 (grey; n ϭ 3). No LTP is induced in anti Nogo-A treated slices in absence of bicuculline (yellow; n ϭ 6). B, LTD shows no obvious difference between the anti-Nogo-A (n ϭ 12) and the control Ab group (n ϭ 9) for the last 20 minutes of maximal LTD ( p ϭ 0.59, t-test). LTD is successfully induced in anti-Nogo-A treated slices in presence of the NMDAR antagonist AP-5 (grey; n ϭ 3). C, J, Expansion of the synaptic modification range. The space between LTP and LTD saturation is defined as the synaptic modification range. Treatment with anti-Nogo-A expands LTP saturation (98%) without altering LTD and by this leads to an enlarged synaptic modification range. D-F, Penetration of anti-Nogo-A antibodies into cortical slices after 1 hr incubation in vitro. D, Motor cortex section taken perpendicularly to the slice surface stained with propidium iodide (red/magenta) as a marker for damaged neurons and with Nissl staining (blue) shows that dying cells are (Figure legend continues.) coordinates. A small region of skull (ϳ300 m in diameter) was manually thinned down to ϳ20 m in thickness using a high-speed drill and a microknife. To reduce respiration-induced movements, the skull was glued to a 400-m-thick stainless steel plate with a central opening for skull access. The plate was screwed to two lateral bars located on either side of the head and fixed to a metal base. The brain of the mouse was then imaged through the thinned skull using a Prairie Ultima IV multiphoton microscope with a Ti-sapphire laser tuned to the excitation wavelength for YFP (920 nm). Stacks of image planes were acquired with a step size of 0.70 m using a water-immersion objective [60ϫ, numerical aperture (NA) 1.1, infrared Olympus objective] at 3.0ϫ magnification. For relocation of the same dendrites at subsequent imaging times, an image stack containing the dendritic structures of interest was taken without magnification with a step size of 2.0 m and the surrounding blood vessels were imaged with a CCD camera. The patterns of blood vessels and neuronal processes in this low-resolution image stack were used for relocating the same dendrites at each subsequent imaging session. After imaging, the plate was detached from the skull, the scalp sutured, and the animal was returned to its home cage until the next imaging session.
For figure illustration, we chose relative sparse labeling regions. Maximum projections were made from 3D image stacks containing in-focus dendritic segments of interest. The images were then thresholded, Gaussian filtered, and contrasted for presentation.
Motor skill learning. During pretraining and training, rats were kept on a standard laboratory diet. Water was given ad libitum. To increase the degree of difficulty and complexity of the motor skill task, the behavioral paradigm was adapted from that of Buitrago et al. (2004b) . To force the animal to realign its body before each pellet retrieval, animals were first pretrained to run to the rear of the cage and return to the slit opening in the cage front in order to retrieve a new food pellet. During pretraining animals received the pellets only by the tongue and in no case by the forelimb to avoid forelimb motor learning prior to antibody treatment. Once acquainted with the setup and the task, osmotic mini-pumps containing the Abs were then implanted 24 h after the last pretraining session. One day later, forelimbreaching training was begun by placing the sugar pellet on a small vertical post 1.5 cm away from the window, a position in which pellets could not be reached by the tongue and were only retrievable by a precise forelimb reaching and grasping movement. Imprecise movements easily displaced the pellet, which was then lost to the animal.
A trial, defined as a new pellet presented to the animal was classified as "successful" (reach, grasp, retrieve, and eat the pellet), "drop" (reach, grasp, and lose pellet during retrieval), or "fail" (knock pellet off the pedestal). A daily session consisted of 150 trials or a maximum time of 1 h for each animal. To analyze the performance during each daily session (within session analysis), the 150 trials were divided into 25 trial bins and the percentage of successfully grasped pellets for each bin was calculated by dividing the number of successes in the respective bin by the total number of trials on the respective day. Precision and fine-tuning of the movement were investigated through first attempt analysis in a subset of animals: First attempts were considered positive when the animal grasped the pellet in a single monolithic movement execution without disruption, hesitation, or repetition of individual movement components. All experiments were performed in a double-blind manner. Animals were coded with random numbers and the groups were mixed within the cages. Experimenters were blind to the treatments throughout all phases of the experiment until completion of data analysis.
Dendritic spine imaging in fixed tissue. Coronal slices containing the forelimb area of M1 were prepared as for electrophysiological experiments. The slices were fixed in 4% PFA overnight at 4°C and washed with PBS. Single-cell labeling was performed by shooting dye-coated particles into the slice with a modified "gene gun" (Helios Gene Gun System; Bio-Rad) as described previously (Rauskolb et al., 2010) . The slices were subsequently kept in PBS for 3 d to allow time for the dye to diffuse. The slices were postfixed in 4% PFA, washed, and stained with DAPI to enable the identification of the cortical layers. Layer 2/3 neurons from the forelimb area of M1 were imaged with a BX61WI FLUOVIEW 1000 (FV1000) Olympus confocal microscope. Image stacks of defined dendritic stretches from the midapical dendritic parts were acquired using a 40ϫ oil objective (NA 1.3), z-step of 0.5 m, and a magnification of 4ϫ.
Detection of the monoclonal anti-Nogo-A Ab in pump infused brains and spinal cords. Four rats received intrathecal pump infusions of the mouse monoclonal anti-Nogo-A Ab 11C7 for 6 d and four untreated control animals were perfused under anesthesia with 4% buffered PFA. Fortymicrometer cryostat sections of the brains and spinal cords were stained free floating with a rat adsorbed anti-mouse IgG Ab coupled to biotin (1:300; Jackson ImmunoResearch), followed by the ABC Elite-DAB peroxidase detection system (Vector Laboratories). In four of four antiNogo-A-infused animals, we could detect mouse IgG immunoreactivity in the spinal cord and in all brain regions. The parallel processed control animal showed no signal except a few endogenous peroxidase-positive erythrocytes. Images of stained sections were acquired using a cooled CCD camera (Cool Snap HQ; Photometrics) and the image analysis software MCID (Elite version 7.0; Imaging Research).
Detection of infused anti-Nogo-A Abs in brain and spinal cord by Western blot.
After intrathecal infusion with the anti-Nogo-A Ab for 6 d, rats were briefly anesthetized with isofluorane and decapitated. The brain and spinal cord were quickly removed, placed on ice for dissection, snap frozen (100 -200 mg in weight), and stored at Ϫ80°C until extraction. Tissue lysates were prepared as described previously (Kempf et al., 2014) . Briefly, the tissue was homogenized in a weight-to-volume ratio of 1:3 in modified RIPA buffer containing 150 mM sodium chloride, 50 mM TrisHCl, pH 8.0, 1 mM phenylmethylsulfonyl fluoride, 1% NP-40, 0.5% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, and protease inhibitors (Roche). The homogenate was centrifuged to pellet the cell and tissue debris (maximally 15-25% of the total homogenate). The protein concentration in the supernatant (between 75% and 85% of total homogenate) was measured with the RC-DC Protein Assay Kit (BioRad). Then, 120 g of protein from each brain region and spinal cord supernatant was run per lane of a Nupage 4 -12% Bis-Tris polyacrylamide gel (Invitrogen). To detect the anti-Nogo-A Ab, a horse-antimouse IgG-rat absorbed-biotinylated secondary Ab (0.5 g/ml, catalog #BA-2001; Vector Laboratories) was used followed by detection of the ABC complex (ABC Complex Elite Kit; Vector Laboratories).
Statistical analysis. For in vivo motor skill learning, two-way mixed ANOVA (between-subjects factor: group of treatment; withinsubjects factor: day of training) was applied. If a significant effect was found for a factor, post hoc tests were performed using Bonferroni's correction for multiple comparisons. For all other experiments, twosampled, two-tailed t tests with unequal sample size were used. Normality and equal variance hypotheses were tested by Kolmogorov-Smirnov test and F test, respectively. All values in the Results section are given as mean Ϯ SEM.
Results

Distribution and synaptic localization of Nogo-A and NgR1
In addition to oligodendrocytes, Nogo-A and NgR1 are known to be expressed in the CNS in subtypes of neurons and at synapses ( showed Nogo-A expression in a subset of pyramidal neurons in layers 2/3 and 5 (Fig. 1A-E) , as well as strong staining in oligodendroglial cells in the corpus callosum (Fig. 1 F, G) . Coimmunostaining of the sections with the presynaptic marker synaptophysin revealed frequent Nogo-A-positive puncta juxtaposed to synaptophysin-positive structures (Fig. 1 I, K-M ) , whereas most NgR1-positive puncta were colocalized with synaptophysin ( Fig. 1H-J ) . Immunogold electron microscopy showed the presence of Nogo-A and NgR1 both in presynaptic and postsynaptic membranes, but with higher Nogo-A levels postsynaptically and enrichment of NgR1 presynaptically (Fig. 1 N, P) . Presynaptic structures were confirmed by the presynaptic marker vGlut-1 (Fig. 1O) . Quantification of these results is shown in Table 1 .
Neutralization of Nogo-A enlarges the synaptic modification range in the motor cortex through LTP enhancement
Fresh, 500 m slices of young adult (5-6 weeks old) rat brains containing the sensory-motor forelimb area were pretreated for at least 1 h with a function-blocking monoclonal Nogo-A Ab (Oertle et al., 2003; Liebscher et al., 2005) or a control IgG Ab at a concentration of 5 g/ml. Ab penetration into the slice to a depth of 60 -100 m was confirmed immunohistochemically (Fig. 2D-FЈ) . Synaptic plasticity was determined by stimulating horizontal fibers in cortical layer 2/3 and measuring the FP amplitude at a distance of 500 m from the stimulation site. LTP was induced with a theta-burst stimulation protocol under local application of a GABA A antagonist. Repeated trains of stimuli were applied until saturation of LTP was reached as described previously Rioult-Pedotti et al., 1998; Rioult-Pedotti et al., 2000) . AntiNogo-A treated slices showed a significant increase in synaptic strength during the final 20 min of saturated LTP (198.7 Ϯ 22.7%, n ϭ 14 slices from 9 animals; Fig. 2A ) compared with control IgG-Ab-treated slices (142.3 Ϯ 4.9%, n ϭ 10 slices from 8 animals; p ϭ 0.038, df ϭ 13.9, t test). To determine whether the effect of anti-Nogo-A Abs on LTP was NMDA receptor (NMDAR)-dependent, NMDARs were blocked with AP-5 in the presence of the anti-Nogo-A Ab; no LTP induction was observed (93.74 Ϯ 0.91, n ϭ 3 slices from 3 animals; Fig. 2A) . A possible role of the GABAergic system could not be analyzed because, as shown in earlier studies (Hess et al., 1996) and confirmed here, no LTP could be induced in the motor cortex without reducing GABAergic inhibition by local application of bicuculline (102.4 Ϯ 2.4% during final 20 min, n ϭ 6 slices from 6 animals; Fig. 2A) .
LTP adapts synaptic transmission in response to synaptic impulse traffic. The opposite event to LTP is LTD. NgR1 was shown to influence LTD induction in the hippocampal Schaffer collateral pathway (Lee et al., 2008; Raiker et al., 2010) , whereas the acute neutralization of Nogo-A did not affect LTD expression (Delekate et al., 2011) . To investigate the influence of antiNogo-A on LTD in the motor cortex, LFS (2 Hz for 15 min) was applied 4 times to the rat sensory-motor cortex slices as described previously (Rioult-Pedotti et al., 2000) . No difference in LTD was observed between anti-Nogo-A-treated and control-Ab-treated slices (anti-Nogo-A: 50.9 Ϯ 5.9%; n ϭ 12 slices from 10 animals; control Ab: 55.4 Ϯ 5.6%; n ϭ 9 slices from 9 animals; p ϭ 0.59; df ϭ 18, t test; Fig. 2B ). Partial involvement of NMDARs in the LTD effect of anti-Nogo-A Abs was suggested by successful LTD induction in the presence of AP-5; however, LTD under these conditions was less than with active NMDARs (69.54 Ϯ 2.05; n ϭ 3 slices from 3 animals; Fig. 2B ).
The strong enhancement in saturated LTP leads to an enlargement of the synaptic modification range upon anti-Nogo-A Ab treatment, as illustrated in Figure 2 , C and J (total range span in percent: anti-Nogo-A: 153%; control Ab: 93%).
To determine whether the observed increase in synaptic potentiation could result from alterations in baseline synaptic transmission, we recorded input-output (I-O) curves and found no significant differences between anti-Nogo-A-and control-Abtreated slices (n ϭ 15 vs 15; p ϭ 0.74 between-subjects; df ϭ 1; 2-way mixed ANOVA; Fig. 2G ). We also analyzed the kinetics of the field response, in particular the different phases of its fast component, as indicated in Figure 2H . We found no significant differences between anti-Nogo-A and control-Ab-treated slices control brain (A, B) . In the antiNogo-A-infused animal (C, D), anti-Nogo-A Abs are detected in the superficial layers and in deeper brain structures. Scale bar, 0.5 mm. ROD, Relative optical density. E, F, Lowmagnification 2D projections from 3D stacks of dendritic branches in the motor cortex of mice treated with IgG control Abs (E) and anti-Nogo-A Abs (F). Scale bar, 20 m. G, H, Highermagnification views of dendritic segments shown in the white boxes of E and F at day 0 (d0) and d6. Arrowheads, Newly formed spines. Scale bar, 2 m. I, Percentage of spine formation (antiNogo-A vs control Ab: p ϭ 0.006; anti-Nogo-A vs control: p ϭ 0.820) and elimination ( p Ͼ 0.1, all pair comparisons) over 6 d in untreated (gray; n ϭ 4), control-Ab-treated (orange; n ϭ 3), and anti-Nogo-A-treated animals (green; n ϭ 4). *p Ͻ 0.05; **p Ͻ 0.01. Imaging location, total spine number, and total dendritic segment number are shown for each animal under different experimental conditions. a
The location of the imaged region is presented as the lateral distance (L) from the midline and the anterior distance (A) from the bregma.
(mean values for anti-Nogo-A vs control IgG Ab for onset latency: 1.29 Ϯ 0.23 vs 1.57 Ϯ 0.13 ms, p ϭ 0.32; time-to-peak: 4.64 Ϯ 0.37 vs 4.42 Ϯ 0.35 ms, p ϭ 0.67; rise time: 0.94 Ϯ 0.08 vs 0.76 Ϯ 0.1 ms, p ϭ 0.18; decay time: 3.59 Ϯ 0.12 vs 2.96 Ϯ 0.43 ms, p ϭ 0.19; in all cases, df ϭ 14, t test). Paired-pulse facilitation is a presynaptic form of short-term plasticity characterized by a transient increase in presynaptic [Ca 2ϩ ] i and neurotransmitter release induced by two closely separated stimuli (Schulz et al., 1994) . We neutralized Nogo-A to test a possible presynaptic function and found no difference in the paired-pulse ratio between anti-Nogo-A-treated slices and control Abs (anti-Nogo-A: n ϭ 12, IgG control Ab: n ϭ 11; p ϭ 0.83, between-subjects; df ϭ 1; 2-way mixed ANOVA; Fig. 2I ).
In summary, these results demonstrate that functional blockade of Nogo-A leads to an enlarged synaptic modification range through an increase of saturated LTP without affecting LTD (Fig.  2C,J ) . Baseline synaptic transmission, presynaptic properties of short-term plasticity, and fast kinetics of the field response are not influenced by anti-Nogo-A Ab treatment.
Blockade of the Nogo receptor NgR1 increases LTP in the motor cortex
Nep 1-40 is a 40 amino-acid peptide from the extracellular loop region of Nogo-A that binds to the Nogo receptor NgR1 and acts as a competitive antagonist (GrandPré et al., 2002) . We evaluated the impact of Nep 1-40 on synaptic strengthening at the layer 2/3 horizontal fiber pathway in the motor cortex. Protocols were identical to the anti-Nogo-A Ab experiments; Nep 1-40 was used at a concentration of 300 nM. Figure 3A shows a significant increase ( p ϭ 0.0047, df ϭ 15, t test) in the magnitude of LTP saturation for Nep 1-40-treated slices (176.4 Ϯ 10.0%, n ϭ 7 slices from 7 animals) compared with controls (141.8 Ϯ 6.3%, n ϭ 9 slices from 6 animals). No influence of Nep 1-40 was observed on baseline synaptic transmission ( p ϭ 0.48, betweensubjects, df ϭ 1; 2-way mixed ANOVA; Fig. 3B ) and paired-pulse facilitation (n ϭ 7 vs 7; p ϭ 0.30, between-subjects; df ϭ 1; 2-way mixed ANOVA; Fig. 3C ). Next, we used a function-blocking Ab against NgR1 and a goat IgG Ab as control at a concentration of 5 g/ml. Abs against NgR1 yielded significantly higher levels of LTP saturation compared with control IgG Ab (anti-NgR1: 159.52 Ϯ 7.79%, 8 slices from 8 animals, control Ab: 126.45 Ϯ 2.07%, 10 slices from 9 animals; p ϭ 0.0032, df ϭ 7.8, t test; Fig.  3D ). Anti-NgR1 Abs did not affect baseline synaptic transmission (anti-NgR1: n ϭ 15; IgG: n ϭ 17; p ϭ 0.94, between-subjects; df ϭ 1; 2-way mixed ANOVA; Fig. 3E ), but paired-pulse measurements revealed significantly higher ratios in antiNgR1-treated slices compared with the respective control Abs ( p ϭ 0.029, between-subjects; df ϭ 1, 2-way mixed ANOVA; Fig. 3F ). Rats were exposed to a complex precision forelimb-reaching task while receiving anti-Nogo-A Abs (green; n ϭ 13), control Abs (orange; n ϭ 16), or no Ab treatment (sham, gray; n ϭ 9). A, Experimental timeline. Day 1 refers to the first day of motor learning. The Ab pumps were implanted 2 d before the first training day. B, Motor skill acquisition over 6 d shown as pellet-grasping success rates over 150 pellets/d. Anti-Nogo-A-treated animals show significantly improved motor learning compared with control IgG-treated and sham animals (p ϭ 0.0067; 2-way mixed ANOVA). No significant difference was observed between IgG controls and sham animals. C, Within-day success rates shown in six bins of 25 pellets/d illustrate improvement in motor learning throughout a daily session (in-session). Anti-Nogo-A-treated animals finish with higher scores toward the end of the first 2 d and reach higher success rates throughout all phases between days 3 and 6. D, Successful first attempts are shown as a measure for fine-tuned movement learning. Animals receiving anti-Nogo-A Ab (n ϭ 8) show significantly higher successful first attempt values on days 3-6 compared with control IgG Ab-treated rats (n ϭ 8; p ϭ 0.089; 2-way mixed ANOVA, Bonferroni's correction) and sham controls (n ϭ 9). *p Ͻ 0.05.
In summary, blockade of NgR1 increases synaptic strength and affects presynaptic properties without altering baseline synaptic transmission.
Anti-Nogo-A Ab treatment increases spine formation in motor cortex layer 5 neurons in vivo
To gain insights into the effects induced by Nogo-A neutralization on synaptic structures in the motor cortex in vivo, we treated animals with function blocking anti-Nogo-A or control Abs by continuous intrathecal infusion over 6 d (Fig. 4A-D) via intrathecal administration and used in vivo transcranial two-photon microscopy (Xu et al., 2009 ) to repeatedly image the apical dendrites of YFP-expressing layer 5 pyramidal neurons (1-monthold mice, YFP-H line; Feng et al., 2000) . Layer 5 neurons were analyzed in this experiment because fluorescent visualization of cortical layer 2/3 cells is only possible through electroporation, which allows the analysis of only a small fraction of cells. Treatment with anti-Nogo-A Abs for 6 d significantly increased the amount of new spines added during that period compared with mice treated with control Abs or mice without any treatment (anti-Nogo-A: 15.3 Ϯ 4.2%, n ϭ 4; control IgG Ab: 6.5 Ϯ 1.2%, n ϭ 3; untreated control: 6.3 Ϯ 0.9%, n ϭ 4; p ϭ 0.018, df ϭ 5, anti-Nogo-A vs control Ab; p ϭ 0.006, df ϭ 6, anti-Nogo-A vs control; p ϭ 0.820, df ϭ 5, control Ab vs control; Fig. 4I ). In contrast to spine formation, spine elimination during the same 6 d period was comparable among the 3 experimental groups (anti-Nogo-A: 9.3 Ϯ 1.1%, control Ab: 10.7 Ϯ 1.2%, untreated control: 10.9 Ϯ 1.2%; p Ͼ 0.1, all pair comparisons).
Together, these results show a negative effect of Nogo-A signaling in regulating spine formation of layer 5 neurons in the motor cortex.
Anti-Nogo-A Ab treatment improves skilled forelimb motor learning in vivo
Adult male rats were trained on a skilled forelimb-reaching task in which a sugar pellet placed on a pedestal had to be accessed through a narrow window, grasped, brought to the mouth, released, and eaten. This task was more difficult than the classical reaching paradigm from a platform and required the acquisition of high precision in the execution of all movement components (Buitrago et al., 2004b) . To allow recovery after the pump implantation, animals started the first learning session 2 d after the surgery. From this time on, they were trained over 6 d with 150 reaches daily. They received function blocking anti-Nogo-A or control Abs by continuous intrathecal infusion during the 6 d period (Fig. 5A) . Abs reached the motor cortex from the pump catheter over the thoracic spinal cord, as described in "AntiNogo-A Ab treatment modulates spine density upon motor learning in rats." To assess possible effects of the catheter, pump, or control Ab on motor learning, we trained an additional sham group. Figure 5B shows the pellet-grasping success rates for the three groups. Rats started with low success rates on day 1 (antiNogo-A: 17.7 Ϯ 2.7%, control IgG Ab: 17.6 Ϯ 1.5%, sham: 11.3 Ϯ 3.6%) and reached scores of ϳ25% on the second session (anti-Nogo-A: 27.3 Ϯ 2.7%, control IgG Ab: 25.0 Ϯ 2.5%, sham: 26.7 Ϯ 2.2%). On the subsequent days, the anti-Nogo-A group showed a significantly steeper learning curve and reached a higher level of successful performance between days 4 and 6 compared with both control groups (anti-Nogo-A: 42.8 Ϯ 3.3%, control IgG Ab: 31.5 Ϯ 2.2%, sham: 29.1 Ϯ 3.0% average success rates for day 4 -6; p ϭ 0.0067, 2-way mixed ANOVA, betweensubjects; 95% confidence interval ϭ 6.99; Bonferroni corrected). Control IgG-treated and sham animals did not significantly differ in their performance.
Several lines of research suggest that motor skill acquisition consists of a slow phase (between training sessions) and a fast phase (within an individual training session) (Karni et al., 1998; Buitrago et al., 2004a) . Improvement in motor learning within a session was assessed by separating the 150 reaches per day into 25-trial bins and dividing the success scores within a bin by the total number of trials on the respective day (Fig. 5C ). Anti-Nogo-A-treated rats finished each training session with higher scores , n ϭ 13 untrained (ut)], control-Ab-treated animals (n ϭ 12 for t, n ϭ 6 for ut), and anti-Nogo-A-treated animals (n ϭ 15 for t, n ϭ 20 for ut). H, Quantification showing spine density for the untrained hemisphere of control versus anti-Nogo-A Ab. *p Ͻ 0.05. than both control groups toward the end of the first 2 d. From day 3 on, anti-Nogo-A-treated rats started their training sessions with higher success rates, suggesting advanced memory consolidation, and maintained elevated scores throughout all phases of the subsequent daily sessions compared with the control groups. Another form of assessing skilled movement acquisition is to measure the degree of precision and fine tuning of the learned movement. To determine this component, we analyzed exclusively first attempts of successfully grasped pellets in a randomly selected subset of the three experimental groups. To be counted as a positive first attempt, the rat had to grasp the pellet in a single monolithic movement execution without disruption, hesitation, or repetition of the individual motion components. Anti-Nogo-A-treated animals achieved significantly higher successful first attempt values on days 3-6 compared with control-Ab-treated rats (day 3 anti-Nogo-A: 11.3 Ϯ 1.7%, control IgG Ab: 6.8 Ϯ 0.8%, sham: 8.7 Ϯ 0.7%; day 4 anti-Nogo-A: 17.4 Ϯ 1.8%, control IgG Ab: 9.5 Ϯ 1.4%, sham: 11.2 Ϯ 0.9%; day 5 anti-Nogo-A: 16.2 Ϯ 2.0%, control IgG Ab: 7.9 Ϯ 1.3%, sham: 10.7 Ϯ 0.8%; day 6 anti-Nogo-A: 14.5 Ϯ 1.6%, control IgG Ab: 9.0 Ϯ 1.1%, sham: 10.3 Ϯ 0.8%; p ϭ 0.0089; 2-way mixed ANOVA, between-subjects; significance obtained for days 3-6, p Ͻ 0.05; Fig. 5D ).
In summary, acute neutralization of Nogo-A with function blocking Abs improved the acquisition of a skilled motor task. These results demonstrate a novel role for Nogo-A in regulating motor skill learning.
Anti-Nogo-A Ab treatment modulates spine density upon motor learning in rats Finally, we investigated whether the acute blockade of Nogo-A influences learning-dependent structural plasticity of dendritic spines in the rat motor cortex. Rats trained as described in the paragraph "Motor skill learning" and were killed 24 h after their last pellet-grasping session. Brain slices were prepared as for electrophysiology, fixed in 4% PFA, labeled with DiI-coated particles using a gene gun (O'Brien and Lummis, 2007; Rauskolb et al., 2010) , and incubated for 3 d to allow time for dye diffusion. The density of dendritic spines was determined for dendrites of layer 2/3 pyramidal cells. Dendritic spine density was significantly higher in apical dendrites of the trained versus the untrained hemisphere of untreated control rats (sham untrained: 1.41 Ϯ 0.05, n ϭ 14; trained: 1.59 Ϯ 0.04, n ϭ 13; p ϭ 0.01, df ϭ 25, t test; Fig. 6 A, B,E) . In rats receiving control IgG Abs, a similar increase in spine density was observed for the trained HS (control Ab untrained: 1.45 Ϯ 0.07, n ϭ 6; control Ab trained: 1.65 Ϯ 0.06, n ϭ 12; p ϭ 0.05, df ϭ 16, t test; Fig. 6F ). In the anti-Nogo-Atreated rats, spine density in the untrained HS was significantly higher compared to the untrained HS of both control groups (anti-Nogo-A untrained HS: 1.64 Ϯ 0.05, n ϭ 20; control Ab untrained: 1.45 Ϯ 0.07, n ϭ 6; p ϭ 0.04; df ϭ 23, t test; Fig. 6C,H ) . However, no significant further increase was detectable on the trained side (anti-Nogo-A untrained HS: 1.64 Ϯ 0.05, n ϭ 20; anti-Nogo-A trained HS: 1.72 Ϯ 0.05, n ϭ 15; p ϭ 0.23, df ϭ 32, t test; Fig. 6 D, G) .
In summary, spine density for the apical dendrites of layer 2/3 pyramidal neurons was equally increased by both, anti-Nogo-A Ab treatment and training. The combination of anti-Nogo-A Ab treatment and training-driven plasticity resulted in indistinguishable spine density levels between trained and untrained hemispheres of the same animals.
Tissue penetration and distribution of CSF transported antiNogo-A Abs after intrathecal administration Anti-Nogo-A Abs were continuously infused for 6 d into the subdural space over the thoracic spinal cord by an osmotic minipump. Very high levels of anti-Nogo-A Abs were detected in the spinal cord tissue close to the inlet by immunohistochemistry and Western blotting (Fig. 7D-F ) . In the brain, the mouse antiNogo-A Abs showed a gradient of penetration from the outer CSF spaces into the tissue. Abs were clearly detectable in the motor cortex, visual cortex, and hippocampus ( Fig. 7 A, B,D-F ) of spinally infused animals. Cellular uptake of the anti-Nogo-A Ab was observed in layer 2/3 cells of the motor cortex (Fig. 7B) .
These experiments show that spinal intrathecal infusion of monoclonal Abs against Nogo-A lead to a distribution of the Ab through the CSF circulation and penetration into brain and spinal cord tissue in adult rodents. support this hypothesis and identify Nogo-A as a molecule that regulates synaptic plasticity and motor learning.
In summary, functional blockade of Nogo-A and NgR1, which are present at synaptic sites in the motor cortex, enhances synaptic gain and capacity through strengthening of connections, the formation of new synapses, and an overall increase of the synaptic modification range in the motor cortex of adult rodents. These changes are accompanied by improvement of motor skill learning in vivo upon treatment with function-blocking antiNogo-A Abs. The relevance of this mechanism for functional recovery and rehabilitation after CNS injury remains to be investigated.
